Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Sillaber

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Journal of Leukocyte Biology|May 1, 1997
Immunophenotypic and functional characterization of human tonsillar mast cellsW Füreder, H C Bankl, J Toth, et al.
Arthritis and Rheumatism|March 4, 1998
Expression of the C5a receptor (CD88) on synovial mast cells in patients with rheumatoid arthritisH P Kiener, M Baghestanian, M Dominkus, et al.
Anticancer Research|January 30, 2008
Mesenchymal stem cells in patients with chronic myelogenous leukaemia or bi-phenotypic Ph+ acute leukaemia are not related to the leukaemic cloneS Wöhrer, W Rabitsch, M Shehata, et al.
Annals of Hematology|February 24, 2001
Effects of interferon-alpha2b treatment on ex vivo differentiation of mast cells from circulating progenitor cells in a patient with systemic mastocytosisG H Schernthaner, E Spanblöchl, W R Sperr, et al.
European Journal of Clinical Investigation|September 12, 2009
Immunosuppression and atypical infections in CML patients treated with dasatinib at 140 mg dailyC Sillaber, H Herrmann, K Bennett, et al.
Blood|December 15, 1994
Kit ligand/mast cell growth factor-independent differentiation of mast cells in myelodysplasia and chronic myeloid leukemic blast crisisP Valent, E Spanblöchl, H C Bankl, et al.
Leukemia|January 1, 1996
A case of malignant mastocytosis with circulating mast cell precursors: biologic and phenotypic characterization of the malignant cloneM Baghestanian, H c Bankl, C Sillaber, et al.
European Journal of Clinical Investigation|June 16, 2009
Elevated tryptase levels selectively cluster in myeloid neoplasms: a novel diagnostic approach and screen marker in clinical haematologyW R Sperr, A El-Samahi, M Kundi, et al.
Leukemia & Lymphoma|July 1, 1996
Mast cell-lineage versus basophil lineage involvement in myeloproliferative and myelodysplastic syndromes: diagnostic role of cell-immunophenotypingH Agis, W J Beil, H C Bankl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 7, 2007
Clinical and prognostic significance of histamine monitoring in patients with CML during treatment with imatinib (STI571)H Agis, W R Sperr, S Herndlhofer, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Journal of Leukocyte Biology|May 1, 1997
Immunophenotypic and functional characterization of human tonsillar mast cellsW Füreder, H C Bankl, J Toth, et al.
Arthritis and Rheumatism|March 4, 1998
Expression of the C5a receptor (CD88) on synovial mast cells in patients with rheumatoid arthritisH P Kiener, M Baghestanian, M Dominkus, et al.
Anticancer Research|January 30, 2008
Mesenchymal stem cells in patients with chronic myelogenous leukaemia or bi-phenotypic Ph+ acute leukaemia are not related to the leukaemic cloneS Wöhrer, W Rabitsch, M Shehata, et al.
Annals of Hematology|February 24, 2001
Effects of interferon-alpha2b treatment on ex vivo differentiation of mast cells from circulating progenitor cells in a patient with systemic mastocytosisG H Schernthaner, E Spanblöchl, W R Sperr, et al.
European Journal of Clinical Investigation|September 12, 2009
Immunosuppression and atypical infections in CML patients treated with dasatinib at 140 mg dailyC Sillaber, H Herrmann, K Bennett, et al.
Blood|December 15, 1994
Kit ligand/mast cell growth factor-independent differentiation of mast cells in myelodysplasia and chronic myeloid leukemic blast crisisP Valent, E Spanblöchl, H C Bankl, et al.
Leukemia|January 1, 1996
A case of malignant mastocytosis with circulating mast cell precursors: biologic and phenotypic characterization of the malignant cloneM Baghestanian, H c Bankl, C Sillaber, et al.
European Journal of Clinical Investigation|June 16, 2009
Elevated tryptase levels selectively cluster in myeloid neoplasms: a novel diagnostic approach and screen marker in clinical haematologyW R Sperr, A El-Samahi, M Kundi, et al.
Leukemia & Lymphoma|July 1, 1996
Mast cell-lineage versus basophil lineage involvement in myeloproliferative and myelodysplastic syndromes: diagnostic role of cell-immunophenotypingH Agis, W J Beil, H C Bankl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 7, 2007
Clinical and prognostic significance of histamine monitoring in patients with CML during treatment with imatinib (STI571)H Agis, W R Sperr, S Herndlhofer, et al.
Pageof 5